Explore the detailed record of transactions filed by Lochner Daniel, Chief Financial Officer. Insider active across 2 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 8 reports have been published. The latest transaction was filed on 9 January 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Daniel Lochner is the Chief Financial Officer at Oyster Point Pharma, Inc., a biopharmaceutical company focused on developing treatments for eye diseases. He is responsible for the financial management of the company, including budgeting and financial reporting.